We previously identified a set of genes which were preferentially induced under hypoxia in CML compared to normal CD34+ cells, and found that ARG2 induction was at least 5-fold greater in CML cells relative to normal CD34+ cells [15]. The gene discussed is ARG2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.